舒脈優膜衣錠 20/5/12.5毫克

国家: 台湾

语言: 中文

来源: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

资料单张 资料单张 (PIL)
09-12-2021
公众评估报告 公众评估报告 (PAR)
23-04-2020

有效成分:

OLMESARTAN MEDOXOMIL;;AMLODIPINE BESYLATE;;HYDROCHLOROTHIAZIDE (EQ TO 3,4-DIHYDROCHLOROTHIAZIDE)

可用日期:

台灣第一三共股份有限公司 台北市中山區松江路223號13樓 (44884303)

ATC代码:

C09DX03

药物剂型:

膜衣錠

组成:

OLMESARTAN MEDOXOMIL (2408005910) MG; AMLODIPINE BESYLATE (2412402210) (=amlodipine 5mg)MG; HYDROCHLOROTHIAZIDE (EQ TO 3,4-DIHYDROCHLOROTHIAZIDE) (4028100600) MG

每包单位数:

鋁箔盒裝

类:

製 劑

处方类型:

須由醫師處方使用

厂商:

DAIICHI SANKYO EUROPE GMBH LUITPOLDSTRABE 1, D-85276 PFAFFENHOFEN, GERMANY DE

治疗领域:

olmesartan medoxomil, amlodipine and hydrochlorothiazide

疗效迹象:

治療高血壓。本品適用於以Olmesartan、Amlodipine、Hydrochlorothiazide其中兩種成分合併治療,仍無法有效控制血壓的高血壓病患。

產品總結:

有效日期: 2026/08/04; 英文品名: Sevikar HCT 20/5/12.5mg

授权日期:

2011-08-04

资料单张

                                Sevikar HCT
®
(OM/AML/HCTZ)
20/5/12.5 mg
025492
40/5/12.5 mg
025494
40/5/25 mg
025493
40/10/12.5 mg
025495
40/10/25 mg
025496
SEVIKAR HCT
®
-
(RAS)
[
(5.1
8.1)]
1
Olmesartan
Amlodipine
Hydrochlorothiazide
2
11
2
Sevikar HCT
®
40/10/25 mg
3
Sevikar HCT
®
20/5/12.5 40/5/12.5
40/5/25
40/10/12.5
40/10/25
Olmesartan medoxomil
(mg)
20
40
40
40
40
Amlodipine equivalent
(mg)
5
5
5
10
10
Hydrochlorothiazide
(mg)
12.5
12.5
25
12.5
25
4
hydrochlorothiazide(anuria)
Sevikar HCT
®
Sevikar HCT
®
aliskiren
(GFR<60 ml/min/1.73 m
2
) (
7.2)
5
5.1
Olmesartan medoxomil
Sevikar HCT
®
2
3
-
Sevikar HCT
®
Hydrochlorothiazide
Thiazide
[
(8.1)]
5.2
OLMESARTAN MEDOXOMIL
-
(
)
olmesartan medoxomil
Sevikar HCT
®
AMLODIPINE
5.3
AMLODIPINE
(
)
5.4
SEVIKAR HCT
®
2.1%Sevikar HCT
®
0.2%1.3%
Sevikar
HCT
®
OLMESARTAN MEDOXOMIL
olmesartan medoxomil
-
-
--
(
)
(
)
Sevikar
HCT
®
olmesartan medoxomil
Sevikar HCT
®
[
(7.2)(12.3)]
ACE
(BUN)
olmesartan medoxomil
Sevikar
HCT
®
olmesartan medoxomil
HYDROCHLOROTHIAZIDE
Thiazide
5.5
AMLODIPINE
amlodipine
(t
1/2
)
56
5.6
Sevikar HCT
®
hydrochlorothiazide
Sevikar HCT
®
olmesartanRASRAS
Hydrochlorothiazide
thiazide
Hydrochlorothiazide
5.7
5.8
HYDROCHLOROTHIAZIDE
thiazide
5.9
Hydrochlorothiazide
hydrochlorothiazide
5.10 SPRUE-LIKE ENTEROPATHY ()
Olmesartan medoxomilolmesartan
olmesartan
Sevikar HCT
®
5.11 --
(RENIN-ANGIOTENSIN ALDOSTERONE SYSTEM; RAAS)
(ACEIs)(ARBs)aliskiren
(
)
(ACEIs)
(ARBs)
aliskiren-
-
(RAAS)
(ACEIs)
(ARBs)
1081405767A
5.12
thiazide
(
)
1081405767A
5.13
(NON-MELANOCYTIC SKIN MALIGNANCIES, NMSC)
hydrochlorothiazide
(HCTZ)(
NON-MELANOCYTIC SKIN
MALIGNANCIES, NMSC
)
6
6.1
SEVIKAR HCT
®
S e v i k a r H C T
®
Sevikar HCT
®
(olmesartan medoxomil/amlodipine/
h y d r o c h l o r o t h i a z i d e 4 0 / 1 0 / 2 5 m g )
o l m e s a r t a n
m e d o x o m i l / a m l o d i p i n e 4 0 / 1 0 m g
o l m e s a r t a n
medoxomil/hydrochlorothiazide 40/25 mg
amlodipine/
hydrochlorothiazide 10/25 mg
2
4
574Sevikar HCT
®
8
65
65
/
Sevikar HCT
®
40/10/25 mg4.0%
olmesartan medoxomil/amlodip
                                
                                阅读完整的文件